Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Han Li

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Genomics|April 6, 2016
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer TherapyChi Han Li, Yangchao Chen
The International Journal of Biochemistry & Cell Biology|June 11, 2013
Targeting long non-coding RNAs in cancers: progress and prospectsChi Han Li, Yangchao Chen
Current Protein & Peptide Science|April 10, 2015
Targeting EZH2 for cancer therapy: progress and perspectiveChi Han Li, Yangchao Chen
Chemosphere|October 19, 2004
Effects of cross-substrate interaction on biotrickling filtration for the control of VOC emissionsWalter Den, Chihpin Huang, Chi-Han Li
European Journal of Cancer (Oxford, England : 1990)|August 4, 2014
Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expressionChi Han Li, Feiyue Xu, Sheungching Chow, et al.
European Journal of Pharmacology|February 26, 2018
Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathwayChi Han Li, Shing Chun Tang, Chi Hin Wong, et al.
Bioengineering & Translational Medicine|May 19, 2025
The hanging-heart chip: A portable microfluidic device for high-throughput generation of contractile embryonic stem cell-derived cardiac spheroidsPei-Tzu Lai, Cheng-Kun He, Chi-Han Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 31, 2013
A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2Yan Wang, Jingyi Ma, Sheung Ching Chow, et al.
International Journal of Cancer|September 6, 2016
EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinomaChi-Han Li, Zhangang Xiao, Joanna Hung-Man Tong, et al.
European Journal of Pharmacology|February 18, 2014
Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinomaZhangang Xiao, Sheung Ching Chow, Chi Han Li, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Genomics|April 6, 2016
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer TherapyChi Han Li, Yangchao Chen
The International Journal of Biochemistry & Cell Biology|June 11, 2013
Targeting long non-coding RNAs in cancers: progress and prospectsChi Han Li, Yangchao Chen
Current Protein & Peptide Science|April 10, 2015
Targeting EZH2 for cancer therapy: progress and perspectiveChi Han Li, Yangchao Chen
Chemosphere|October 19, 2004
Effects of cross-substrate interaction on biotrickling filtration for the control of VOC emissionsWalter Den, Chihpin Huang, Chi-Han Li
European Journal of Cancer (Oxford, England : 1990)|August 4, 2014
Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expressionChi Han Li, Feiyue Xu, Sheungching Chow, et al.
European Journal of Pharmacology|February 26, 2018
Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathwayChi Han Li, Shing Chun Tang, Chi Hin Wong, et al.
Bioengineering & Translational Medicine|May 19, 2025
The hanging-heart chip: A portable microfluidic device for high-throughput generation of contractile embryonic stem cell-derived cardiac spheroidsPei-Tzu Lai, Cheng-Kun He, Chi-Han Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 31, 2013
A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2Yan Wang, Jingyi Ma, Sheung Ching Chow, et al.
International Journal of Cancer|September 6, 2016
EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinomaChi-Han Li, Zhangang Xiao, Joanna Hung-Man Tong, et al.
European Journal of Pharmacology|February 18, 2014
Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinomaZhangang Xiao, Sheung Ching Chow, Chi Han Li, et al.
Pageof 4